The mechanistic basis linking cytokine storm to thrombosis in COVID-19.

COVID-19 Clots Coagulopathy Cytokine storm SARS-CoV2 Thrombosis

Journal

Thrombosis update
ISSN: 2666-5727
Titre abrégé: Thromb Update
Pays: England
ID NLM: 9918249114406676

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 01 02 2022
revised: 26 04 2022
accepted: 09 05 2022
medline: 1 8 2022
pubmed: 1 8 2022
entrez: 15 4 2024
Statut: ppublish

Résumé

It is now well established that infection with SARS-CoV-2 resulting in COVID-19 disease includes a severely symptomatic subset of patients in whom an aggressive and/or dysregulated host immune response leads to cytokine storm syndrome (CSS) that may be further complicated by thrombotic events, contributing to the severe morbidity and mortality observed in COVID-19. This review provides a brief overview of cytokine storm in COVID-19, and then presents a mechanistic discussion of how cytokine storm affects integrated pathways in thrombosis involving the endothelium, platelets, the coagulation cascade, eicosanoids, auto-antibody mediated thrombosis, and the fibrinolytic system.

Identifiants

pubmed: 38620974
doi: 10.1016/j.tru.2022.100110
pii: S2666-5727(22)00014-1
pmc: PMC9116969
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

100110

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Adam Wolf (A)

Sathyamoorthy Laboratory, TCU School of Medicine, Fort Worth, TX, United States.
TCU School of Medicine, Fort Worth, TX, United States.

Faria Khimani (F)

Sathyamoorthy Laboratory, TCU School of Medicine, Fort Worth, TX, United States.
TCU School of Medicine, Fort Worth, TX, United States.

Braian Yoon (B)

Sathyamoorthy Laboratory, TCU School of Medicine, Fort Worth, TX, United States.
TCU School of Medicine, Fort Worth, TX, United States.

Coltin Gerhart (C)

Sathyamoorthy Laboratory, TCU School of Medicine, Fort Worth, TX, United States.
TCU School of Medicine, Fort Worth, TX, United States.

Dakota Endsley (D)

Sathyamoorthy Laboratory, TCU School of Medicine, Fort Worth, TX, United States.
TCU School of Medicine, Fort Worth, TX, United States.

Anish K Ray (AK)

Cook Children's Medical Center, Fort Worth, TX, United States.
Department of Pediatrics, TCU School of Medicine, Fort Worth, TX, United States.

Angelito F Yango (AF)

Department of Medicine, TCU School of Medicine, Fort Worth, TX, United States.
Annette C. and Harold C. Simmons Transplant Institute, Baylor All Saints Medical Center, Fort Worth, TX, USA.

Stuart D Flynn (SD)

TCU School of Medicine, Fort Worth, TX, United States.

Gregory Y H Lip (GYH)

Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
Department of Clinical Medicine, Aalborg, Denmark.

Stevan A Gonzalez (SA)

Department of Medicine, TCU School of Medicine, Fort Worth, TX, United States.
Annette C. and Harold C. Simmons Transplant Institute, Baylor All Saints Medical Center, Fort Worth, TX, USA.

Mohanakrishnan Sathyamoorthy (M)

Sathyamoorthy Laboratory, TCU School of Medicine, Fort Worth, TX, United States.
Department of Medicine, TCU School of Medicine, Fort Worth, TX, United States.
Consultants in Cardiovascular Medicine and Science - Fort Worth, PLLC, Fort Worth, TX, United States.

Classifications MeSH